STAT3 and rhabdomyosarcoma: We also found that inhibition of STAT3 activation in vivo by STAT3 inhibitor greatly increased CD8+ and CD8+IFN-γ+ T cells in the spleen and lymph nodes of rhabdomyosarcoma-bearing wild-type mice.